ARNOL CHACON: Open Payments
NPI 1710588413 · PALM SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,159 in 100 payments from 12 companies in 2025. Trend: 2023 $3,169 · 2024 $2,333 · 2025 $2,159
Food & beverage: $2,060Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $563 |
| Janssen Biotech, Inc. | 16 | $417 |
| UCB, Inc. | 18 | $239 |
| Amgen Inc. | 11 | $226 |
| PFIZER INC. | 9 | $190 |
| Novartis Pharmaceuticals Corporation | 10 | $181 |
| GENZYME CORPORATION | 5 | $162 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Radius Health, Inc. | 2 | $42 |
| Mallinckrodt Hospital Products Inc. | 1 | $38 |
Products named: RINVOQ, TREMFYA, Bimzelx, XELJANZ, KEVZARA, COSENTYX, SKYRIZI, ENBREL.
Industry payments across FL — which companies pay providers there.
